Skip to content

Docs (opens in a new tab)Pricing Ideas Benchmark

Sign in Sign up

A

ARVN

ARVINAS, INC.

NASDAQHealthcareBiotechnologyUS

NASDAQ · Healthcare · Biotechnology · US

$8.29

−0.24%

FinancialsValuationProfitabilityGrowthCapitalMomentum

EarningsOwnershipNewsIdeas

Research · Sep 3, 2026
ARVN: FY25 Deep Dive
Arvinas FY25 at $263M. NI $-81M; EPS $-1.28.

Data parsed from primary filings: SEC EDGAR · EDINET · HKEX · CNINFO · DART. Prices delayed 15 minutes.

Workspace|Docs (opens in a new tab)|Pricing|Research|Methodology|Privacy|Disclaimer|Contact|© 2026 LIL GREBE INC.